Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline vs Vancomycin for ABSSSI with MRSA Risk
NCT02582203Phase 4Completed
- Sponsor
- Wayne State University
- Start
- Feb 2012
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ceftaroline fosamil in acute bacterial skin and skin structure infection (ABSSSI), sponsored by Wayne State University. Started Feb 2012; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT02582203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02582203.